Brennan Daniel J.
Director · Officer · MDGL, WAT, BSX
As of 2026-09-16, Brennan Daniel J. has 44 Form 4 transactions on record across 3 companies — 6 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Reconstructed holdings
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2025-02-19 | BSX | Sale | 67,333 @ $105.24 | $7.1M | −23.0% of holding | 225,808 | Form 4 |
| 2025-02-18 | BSX | Sale | 14,630 @ $104.67 | $1.5M | −5.9% of holding | 232,618 | Form 4 |
| 2025-02-18 | BSX | Sale | 2,900 @ $104.08 | $302K | −1.2% of holding | 247,248 | Form 4 |
| 2025-02-12 | BSX | Sale | 15,087 @ $105.07 | $1.6M | −5.9% of holding | 241,451 | Form 4 |
| 2025-01-03 | BSX | Sale | 9,689 @ $89.86 | $871K | −4.1% of holding | 223,921 | Form 4 |
39 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-06-17 | MDGL | Award / grant | 404 | 1,371 | Form 4 |
| 2026-06-17 | MDGL | Award / grant | 681 | 681 | Form 4 |
| 2026-02-25 | WAT | Award / grant | 23 | 1,355 | Form 4 |
| 2026-02-25 | WAT | Award / grant | 57 | 57 | Form 4 |
| 2026-01-02 | WAT | Award / grant | 307 | 1,332 | Form 4 |
| 2026-01-02 | WAT | Award / grant | 828 | 828 | Form 4 |
| 2025-08-01 | MDGL | Award / grant | 1,705 | 1,705 | Form 4 |
| 2025-08-01 | MDGL | Award / grant | 967 | 967 | Form 4 |
| 2025-02-19 | BSX | Option exercise | 18,533 | 251,151 | Form 4 |
| 2025-02-19 | BSX | Option exercise | 15,642 | 283,658 | Form 4 |
| 2025-02-19 | BSX | Option exercise | 9,483 | 293,141 | Form 4 |
| 2025-02-19 | BSX | Option exercise | 16,865 | 268,016 | Form 4 |
| 2025-02-19 | BSX | Option exercise | 18,533 | 37,067 | Form 4 |
| 2025-02-19 | BSX | Option exercise | 16,865 | 0 | Form 4 |
| 2025-02-19 | BSX | Option exercise | 9,483 | 37,934 | Form 4 |
| 2025-02-19 | BSX | Option exercise | 15,642 | 31,285 | Form 4 |
| 2025-02-17 | BSX | Withheld for tax | 2,217 | 250,148 | Form 4 |
| 2025-02-17 | BSX | Option exercise | 4,584 | 0 | Form 4 |
| 2025-02-17 | BSX | Option exercise | 4,584 | 252,365 | Form 4 |
| 2025-02-16 | BSX | Withheld for tax | 2,052 | 247,781 | Form 4 |
| 2025-02-16 | BSX | Option exercise | 4,243 | 249,833 | Form 4 |
| 2025-02-16 | BSX | Option exercise | 4,243 | 4,243 | Form 4 |
| 2025-02-14 | BSX | Withheld for tax | 2,110 | 245,590 | Form 4 |
| 2025-02-14 | BSX | Option exercise | 4,362 | 8,725 | Form 4 |
| 2025-02-14 | BSX | Option exercise | 4,362 | 247,700 | Form 4 |
| 2025-02-13 | BSX | Award / grant | 23,031 | 23,031 | Form 4 |
| 2025-02-13 | BSX | Award / grant | 8,950 | 8,950 | Form 4 |
| 2025-02-12 | BSX | Option exercise | 15,087 | 256,538 | Form 4 |
| 2025-02-12 | BSX | Withheld for tax | 1,767 | 243,338 | Form 4 |
| 2025-02-12 | BSX | Option exercise | 3,654 | 10,963 | Form 4 |
| 2025-02-12 | BSX | Option exercise | 3,654 | 245,105 | Form 4 |
| 2025-02-12 | BSX | Option exercise | 15,087 | 0 | Form 4 |
| 2025-02-11 | BSX | Withheld for tax | 16,414 | 241,451 | Form 4 |
| 2025-02-11 | BSX | Award / grant | 33,944 | 257,865 | Form 4 |
| 2025-01-02 | WAT | Award / grant | 818 | 818 | Form 4 |
| 2025-01-02 | WAT | Award / grant | 319 | 1,025 | Form 4 |
| 2025-01-01 | BSX | Withheld for tax | 5,212 | 233,610 | Form 4 |
| 2025-01-01 | BSX | Option exercise | 14,901 | 238,822 | Form 4 |
| 2025-01-01 | BSX | Option exercise | 14,901 | 0 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.